AI
Sunday, June 03, 2018 2:01:58 PM
If "Dual Denial" off-to-the-races.
Yearly Rev of the 13 > $172B.
Post # 39541
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138868669
For $5B amount, this would in all probability be a judgment from trial.
Estimating, $1.2B or 0.75 per share, most likely paid on pro-rate marketshare basis of the 13. Could get as high as $3.2B.
Supplemental Info:
Merck subsidiary Idenix wins $2.54B in HCV treatment suit against Gilead in largest U.S. patent infringement verdict ever.
Gilead plans to file an appeal of the verdict.
http://www.ipwatchdog.com/2017/01/05/merck-subsidiary-idenix-wins-largest-patent-infringement-verdict/id=76243/
DISH Network and EchoStar agreed to pay TiVo $500 million, including an initial payment of $300 million with the remaining $200 million distributed in six equal annual installments between 2012 and 2017.
https://www.engadget.com/2011/05/02/dish-network-will-pay-tivo-500-million-to-settle-dvr-lawsuit/
Marvell Technology Group Ltd will pay Carnegie Mellon University $750 million to settle a nearly seven-year-old lawsuit accusing it of infringing two hard disk drive patents held.
https://arstechnica.com/tech-policy/2016/02/marvell-will-pay-750m-to-carnegie-mellon-university-in-massive-patent-settlement/
Other similarly massive payouts in tech patent cases include Blackberry (then Research in Motion) paying $612.5 million to patent-holding company NTP in 2006 when it was facing an injunction. In December 2015, Samsung was compelled to pay $548 million as part of the blockbuster Apple v. Samsung cases, and the company ultimately could have to pay more.
Some medical and pharmaceutical patent cases have resulted in even bigger larger payouts. In 2013, Sun Pharmaceuticals and Teva agreed to pay $2.15 billion to resolve a patent lawsuit over Pfizer's Protonix acid-reflux drug. In 2014, Medtronic agreed to pay Edwards Lifesciences at least $1.1 billion in a case involving heart valves. Medtronic was the payor in another massive settlement in 2005, when the company agreed to pay $1.35 billion to a surgeon and his company who sued over spinal surgery patents.
https://www.reuters.com/article/us-marvell-technlgy-carnegiemellon/marvell-technology-to-pay-carnegie-mellon-750-million-over-patents-idUSKCN0VQ2YE
All JMHO.
Yearly Rev of the 13 > $172B.
Post # 39541
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138868669
For $5B amount, this would in all probability be a judgment from trial.
Estimating, $1.2B or 0.75 per share, most likely paid on pro-rate marketshare basis of the 13. Could get as high as $3.2B.
Supplemental Info:
Merck subsidiary Idenix wins $2.54B in HCV treatment suit against Gilead in largest U.S. patent infringement verdict ever.
Gilead plans to file an appeal of the verdict.
http://www.ipwatchdog.com/2017/01/05/merck-subsidiary-idenix-wins-largest-patent-infringement-verdict/id=76243/
DISH Network and EchoStar agreed to pay TiVo $500 million, including an initial payment of $300 million with the remaining $200 million distributed in six equal annual installments between 2012 and 2017.
https://www.engadget.com/2011/05/02/dish-network-will-pay-tivo-500-million-to-settle-dvr-lawsuit/
Marvell Technology Group Ltd will pay Carnegie Mellon University $750 million to settle a nearly seven-year-old lawsuit accusing it of infringing two hard disk drive patents held.
https://arstechnica.com/tech-policy/2016/02/marvell-will-pay-750m-to-carnegie-mellon-university-in-massive-patent-settlement/
Other similarly massive payouts in tech patent cases include Blackberry (then Research in Motion) paying $612.5 million to patent-holding company NTP in 2006 when it was facing an injunction. In December 2015, Samsung was compelled to pay $548 million as part of the blockbuster Apple v. Samsung cases, and the company ultimately could have to pay more.
Some medical and pharmaceutical patent cases have resulted in even bigger larger payouts. In 2013, Sun Pharmaceuticals and Teva agreed to pay $2.15 billion to resolve a patent lawsuit over Pfizer's Protonix acid-reflux drug. In 2014, Medtronic agreed to pay Edwards Lifesciences at least $1.1 billion in a case involving heart valves. Medtronic was the payor in another massive settlement in 2005, when the company agreed to pay $1.35 billion to a surgeon and his company who sued over spinal surgery patents.
https://www.reuters.com/article/us-marvell-technlgy-carnegiemellon/marvell-technology-to-pay-carnegie-mellon-750-million-over-patents-idUSKCN0VQ2YE
All JMHO.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
